lker, a pediatric dentist with the Riley Hospital for Children at IU Health's Craniofacial Anomalies Team in Indianapolis
, says her team uses the DynaCleft®
plus nasal elevator method in their protocol because they believe the burden of care on parents of cleft babies is too high with the NAM method. The NAM requires continuous adjustments over a three-to-six month period, so parents must commit to bringing their baby in weekly for custom shaping of the appliance by a specially-trained orthodontist. The time and out-of-pocket expenses required simply to attend appointments can be prohibitive for many families.
"Although NAM therapy is considered to be one of the most effective forms of pre-surgical orthopedics, it is also one of the most costly and time-consuming," says Dr. Walker. "NAM is a labor-intensive technique that requires frequent visits to our craniofacial center over several months. Such requirements can be problematic for many parents who commonly travel great distances as well as having other responsibilities that cannot be put on hold during these first crucial months of the infant's life."
According to the study's lead author Dr. Luis Monasterio, a specialist with more than 40 years experience treating cleft lip and palate babies, this new topical technique may also make babies happier. In the published study, he described the experience of wearing an intra-oral orthodontic appliance from a newborn baby's perspective: "If I was an infant with complete unilateral cleft lip and palate, and soon after my birth someone would place an appliance inside my mouth, a nasal antenna which would obstruct my nasal passage, and cover around my mouth with paper tape, I would certainly not be a happy baby."
The DynaCleft® device, developed by Canica Design Inc. in Ottawa, Ontario is the only FDA, EU and Health Canada-approved mePage: 1 2 3 Related medicine technology :1
. Shire Announces that the US Food and Drug Administration has Responded to its Citizen Petition for Adderall XR and has Approved One Abbreviated New Drug Application for Generic Adderall XR2
. Statement from Mary Vogt, President of Home Access Health Corporation, manufacturer of the Home Access HIV-1 test system, the only over-the-counter HIV test previously approved by the FDA for at-home use.3
. Hologic Human Papillomavirus (HPV) High-Risk Test Approved for Use in The Netherlands Population Cervical Screening Programme4
. Life Technologies Acquires Pinpoint Genomics and CLIA-Approved Lung Cancer Test5
. Stem Cell Supplement Approved In Taiwan6
. InkSure Introduces FDA Approved High Security Taggants for Direct Food Contact7
. First FDA approved subcutaneous implantable defibrillator available for patients at risk for sudden cardiac arrest8
. Shares of Oramed Pharmaceuticals Are Approved for Listing on the Nasdaq Capital Market9
. Experienced Surgeon Vs. FDA-Approved Robot10
. SafeCode Drug Technologies to Hire Project Manager to Market FDA Approved Painless Injection Device11
. Roche/Chugais Bitopertin Will Garner Nearly $1.5 Billion in Major-Market Sales in 2022 as the First Approved Treatment for Negative Symptoms in Schizophrenia